Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicityin vitroandin vivo

Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons

(2012) Johnson J. Liu et al.   BIOCHEMICAL PHARMACOLOGY

Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs

(2012) Johnson J. Liu et al.   CURRENT CANCER DRUG TARGETS

Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent

(2012) Siqing Fu et al.   MOLECULAR CANCER THERAPEUTICS

Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents

(2012) Z. D. Liang et al.   MOLECULAR CANCER THERAPEUTICS

Oxaliplatin: a review of approved uses

(2011) Alexander Stein et al.   EXPERT OPINION ON PHARMACOTHERAPY

Oxaliplatin Transport Mediated by Organic Cation/Carnitine Transporters OCTN1 and OCTN2 in Overexpressing Human Embryonic Kidney 293 Cells and Rat Dorsal Root Ganglion Neurons

(2011) N. N. Jong et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions

(2010) Giuliano Ciarimboli et al.   AMERICAN JOURNAL OF PATHOLOGY

Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator

(2010) Seiko Ishida et al.   CANCER CELL

Differential Expression of ATP7A, ATP7B and CTR1 in Adult Rat Dorsal Root Ganglion Tissue

(2010) Virginia Ip et al.   Molecular Pain

Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity

(2009) Johnson J. Liu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Oxaliplatin-Induced Loss of Phosphorylated Heavy Neurofilament Subunit Neuronal Immunoreactivity in Rat Drg Tissue

(2009) Stephen MF Jamieson et al.   Molecular Pain